{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T06:49:50Z","timestamp":1793083790076,"version":"4.5.0"},"reference-count":57,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,4,11]],"date-time":"2020-04-11T00:00:00Z","timestamp":1586563200000},"content-version":"vor","delay-in-days":376,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.ymthe.2018.12.009","type":"journal-article","created":{"date-parts":[[2018,12,14]],"date-time":"2018-12-14T10:13:45Z","timestamp":1544782425000},"page":"729-734","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":85,"title":["mRNA-Based Genetic Reprogramming"],"prefix":"10.1016","volume":"27","author":[{"given":"Luigi","family":"Warren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cory","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2018.12.009_bib1","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","article-title":"Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors","volume":"126","author":"Takahashi","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2018.12.009_bib2","article-title":"First-of-its-kind clinical trial will use reprogrammed adult stem cells to treat Parkinson\u2019s","author":"Normile","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2018.12.009_bib3","first-page":"622","article-title":"The developmental capacity of nuclei taken from intestinal epithelium cells of feeding tadpoles","volume":"10","author":"Gurdon","year":"1962","journal-title":"J.\u00a0Embryol. Exp. Morphol."},{"key":"10.1016\/j.ymthe.2018.12.009_bib4","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/nature08533","article-title":"Forcing cells to change lineages","volume":"462","author":"Graf","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2018.12.009_bib5","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/0092-8674(87)90585-X","article-title":"Expression of a single transfected cDNA converts fibroblasts to myoblasts","volume":"51","author":"Davis","year":"1987","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2018.12.009_bib6","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","article-title":"Induction of pluripotent stem cells from adult human fibroblasts by defined factors","volume":"131","author":"Takahashi","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2018.12.009_bib7","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.stem.2012.05.005","article-title":"Induced pluripotent stem cells: past, present, and future","volume":"10","author":"Yamanaka","year":"2012","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.ymthe.2018.12.009_bib8","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1126\/science.1164270","article-title":"Generation of mouse induced pluripotent stem cells without viral vectors","volume":"322","author":"Okita","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2018.12.009_bib9","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1126\/science.1162494","article-title":"Induced pluripotent stem cells generated without viral integration","volume":"322","author":"Stadtfeld","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2018.12.009_bib10","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1126\/science.1172482","article-title":"Human induced pluripotent stem cells free of vector and transgene sequences","volume":"324","author":"Yu","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2018.12.009_bib11","doi-asserted-by":"crossref","first-page":"135","DOI":"10.2174\/1566523024605591","article-title":"Adenovirus as an integrating vector","volume":"2","author":"Mitani","year":"2002","journal-title":"Curr. Gene Ther."},{"key":"10.1016\/j.ymthe.2018.12.009_bib12","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1038\/sj.gt.3302074","article-title":"Illegitimate DNA integration in mammalian cells","volume":"10","author":"W\u00fcrtele","year":"2003","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2018.12.009_bib13","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1002\/jcp.25597","article-title":"RNA-generated and gene-edited induced pluripotent stem cells for disease modeling and therapy","volume":"232","author":"Kehler","year":"2017","journal-title":"J.\u00a0Cell. Physiol."},{"key":"10.1016\/j.ymthe.2018.12.009_bib14","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.stem.2009.04.005","article-title":"Generation of induced pluripotent stem cells using recombinant proteins","volume":"4","author":"Zhou","year":"2009","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.ymthe.2018.12.009_bib15","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.stem.2009.05.005","article-title":"Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins","volume":"4","author":"Kim","year":"2009","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.ymthe.2018.12.009_bib16","doi-asserted-by":"crossref","first-page":"e0182497","DOI":"10.1371\/journal.pone.0182497","article-title":"Synthetic mRNA is a more reliable tool for the delivery of DNA-targeting proteins into the cell nucleus than fusion with a protein transduction domain","volume":"12","author":"Leontovyc","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ymthe.2018.12.009_bib17","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s13238-016-0362-6","article-title":"Reprogramming cell fates by small molecules","volume":"8","author":"Ma","year":"2017","journal-title":"Protein Cell"},{"key":"10.1016\/j.ymthe.2018.12.009_bib18","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.stem.2010.08.012","article-title":"Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA","volume":"7","author":"Warren","year":"2010","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.ymthe.2018.12.009_bib19","doi-asserted-by":"crossref","first-page":"348","DOI":"10.2183\/pjab.85.348","article-title":"Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome","volume":"85","author":"Fusaki","year":"2009","journal-title":"Proc. Jpn. Acad., Ser. B, Phys. Biol. Sci."},{"key":"10.1016\/j.ymthe.2018.12.009_bib20","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.stem.2013.06.001","article-title":"Efficient generation of human iPSCs by a synthetic self-replicative RNA","volume":"13","author":"Yoshioka","year":"2013","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.ymthe.2018.12.009_bib21","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/0076-6879(89)80090-4","article-title":"Synthesis of long, capped transcripts in\u00a0vitro by SP6 and T7 RNA polymerases","volume":"180","author":"Yisraeli","year":"1989","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.ymthe.2018.12.009_bib22","doi-asserted-by":"crossref","first-page":"4009","DOI":"10.1182\/blood-2006-04-015024","article-title":"Modification of antigen-encoding RNA increases stability, translational efficacy, and T-cell stimulatory capacity of dendritic cells","volume":"108","author":"Holtkamp","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2018.12.009_bib23","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.bbrc.2005.03.067","article-title":"Optimized transfection of mRNA transcribed from a d(A\/T)100 tail-containing vector","volume":"330","author":"Elango","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ymthe.2018.12.009_bib24","doi-asserted-by":"crossref","first-page":"e14397","DOI":"10.1371\/journal.pone.0014397","article-title":"Activation of pluripotency genes in human fibroblast cells by a novel mRNA based approach","volume":"5","author":"Plews","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ymthe.2018.12.009_bib25","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.biomaterials.2011.09.062","article-title":"Activation of pluripotency-associated genes in mouse embryonic fibroblasts by non-viral transfection with in\u00a0vitro-derived mRNAs encoding Oct4, Sox2, Klf4 and cMyc","volume":"33","author":"Tavernier","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.ymthe.2018.12.009_bib26","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.bbrc.2010.02.150","article-title":"Reprogramming of human fibroblasts to pluripotent stem cells using mRNA of four transcription factors","volume":"394","author":"Yakubov","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ymthe.2018.12.009_bib27","doi-asserted-by":"crossref","first-page":"e11756","DOI":"10.1371\/journal.pone.0011756","article-title":"Innate immune suppression enables frequent transfection with RNA encoding reprogramming proteins","volume":"5","author":"Angel","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ymthe.2018.12.009_bib28","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/jb\/mvm032","article-title":"Antiviral signaling through pattern recognition receptors","volume":"141","author":"Kawai","year":"2007","journal-title":"J.\u00a0Biochem."},{"key":"10.1016\/j.ymthe.2018.12.009_bib29","doi-asserted-by":"crossref","first-page":"e142","DOI":"10.1093\/nar\/gkr695","article-title":"Generating the optimal mRNA for therapy: HPLC purification eliminates immune activation and improves translation of nucleoside-modified, protein-encoding mRNA","volume":"39","author":"Karik\u00f3","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymthe.2018.12.009_bib30","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/0092-8674(95)90076-4","article-title":"Vaccinia virus encodes a soluble type I interferon receptor of novel structure and broad species specificity","volume":"81","author":"Symons","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2018.12.009_bib31","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.immuni.2005.06.008","article-title":"Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA","volume":"23","author":"Karik\u00f3","year":"2005","journal-title":"Immunity"},{"key":"10.1016\/j.ymthe.2018.12.009_bib32","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1038\/mt.2008.200","article-title":"Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability","volume":"16","author":"Karik\u00f3","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2018.12.009_bib33","first-page":"523","article-title":"Naturally occurring nucleoside modifications suppress the immunostimulatory activity of RNA: implication for therapeutic RNA development","volume":"10","author":"Karik\u00f3","year":"2007","journal-title":"Curr. Opin. Drug Discov. Devel."},{"key":"10.1016\/j.ymthe.2018.12.009_bib34","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/nprot.2013.019","article-title":"Reprogramming human fibroblasts to pluripotency using modified mRNA","volume":"8","author":"Mandal","year":"2013","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ymthe.2018.12.009_bib35","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/522026a","article-title":"Business: The billion-dollar biotech","volume":"522","author":"Dolgin","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2018.12.009_bib36","doi-asserted-by":"crossref","first-page":"12759","DOI":"10.1073\/pnas.0904825106","article-title":"Stoichiometric and temporal requirements of Oct4, Sox2, Klf4, and c-Myc expression for efficient human iPSC induction and differentiation","volume":"106","author":"Papapetrou","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2018.12.009_bib37","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.stem.2009.08.001","article-title":"Hypoxia enhances the generation of induced pluripotent stem cells","volume":"5","author":"Yoshida","year":"2009","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.ymthe.2018.12.009_bib38","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.cell.2012.09.034","article-title":"Activation of innate immunity is required for efficient nuclear reprogramming","volume":"151","author":"Lee","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2018.12.009_bib39","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1016\/j.bbrc.2016.08.159","article-title":"Differential effects of toll-like receptor stimulation on mRNA-driven myogenic conversion of human and mouse fibroblasts","volume":"478","author":"Lee","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ymthe.2018.12.009_bib40","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.celrep.2016.03.084","article-title":"Optimal ROS signaling is critical for nuclear reprogramming","volume":"15","author":"Zhou","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.ymthe.2018.12.009_bib41","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1038\/ncb2835","article-title":"Early role for IL-6 signalling during generation of induced pluripotent stem cells revealed by heterokaryon RNA-Seq","volume":"15","author":"Brady","year":"2013","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.ymthe.2018.12.009_bib42","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/nbt.3070","article-title":"A comparison of non-integrating reprogramming methods","volume":"33","author":"Schlaeger","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2018.12.009_bib43","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/srep00657","article-title":"Feeder-free derivation of human induced pluripotent stem cells with messenger RNA","volume":"2","author":"Warren","year":"2012","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2018.12.009_bib44","doi-asserted-by":"crossref","DOI":"10.1002\/9780470151808.sc04a06s27","article-title":"Feeder-free reprogramming of human fibroblasts with messenger RNA","volume":"27","author":"Warren","year":"2013","journal-title":"Curr. Protoc. Stem Cell Biol."},{"key":"10.1016\/j.ymthe.2018.12.009_bib45","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1089\/hum.2015.045","article-title":"Efficient reprogramming of human fibroblasts and blood-derived endothelial progenitor cells using nonmodified RNA for reprogramming and immune evasion","volume":"26","author":"Poleganov","year":"2015","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2018.12.009_bib46","doi-asserted-by":"crossref","first-page":"21840","DOI":"10.3390\/ijms151221840","article-title":"Pluripotent state induction in mouse embryonic fibroblast using mRNAs of reprogramming factors","volume":"15","author":"El-Sayed","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymthe.2018.12.009_bib47","doi-asserted-by":"crossref","first-page":"433","DOI":"10.5966\/sctm.2013-0138","article-title":"Footprint-free human induced pluripotent stem cells from articular cartilage with redifferentiation capacity: a first step toward a clinical-grade cell source","volume":"3","author":"Borestr\u00f6m","year":"2014","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/j.ymthe.2018.12.009_bib48","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ymben.2013.02.004","article-title":"mRNA transfection-based, feeder-free, induced pluripotent stem cells derived from adipose tissue of a 50-year-old patient","volume":"18","author":"Heng","year":"2013","journal-title":"Metab. Eng."},{"key":"10.1016\/j.ymthe.2018.12.009_bib49","doi-asserted-by":"crossref","first-page":"14363","DOI":"10.1038\/s41598-018-32645-2","article-title":"Urine-derived cells provide a readily accessible cell type for feeder-free mRNA reprogramming","volume":"8","author":"Gaignerie","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2018.12.009_bib50","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1182\/blood.V98.1.49","article-title":"Highly efficient gene delivery by mRNA electroporation in human hematopoietic cells: superiority to lipofection and passive pulsing of mRNA and to electroporation of plasmid cDNA for tumor antigen loading of dendritic cells","volume":"98","author":"Van Tendeloo","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2018.12.009_bib51","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1089\/hum.2008.068","article-title":"Chimeric receptor mRNA transfection as a tool to generate antineoplastic lymphocytes","volume":"20","author":"Rabinovich","year":"2009","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2018.12.009_bib52","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/nature19764","article-title":"In\u00a0vitro and ex\u00a0vivo strategies for intracellular delivery","volume":"538","author":"Stewart","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2018.12.009_bib53","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/nmeth.3507","article-title":"Automated, high-throughput derivation, characterization and differentiation of induced pluripotent stem cells","volume":"12","author":"Paull","year":"2015","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ymthe.2018.12.009_bib54","doi-asserted-by":"crossref","first-page":"e94231","DOI":"10.1371\/journal.pone.0094231","article-title":"Rapid and efficient conversion of integration-free human induced pluripotent stem cells to GMP-grade culture conditions","volume":"9","author":"Durruthy-Durruthy","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ymthe.2018.12.009_bib55","doi-asserted-by":"crossref","first-page":"4A.6.1","DOI":"10.1002\/cpsc.18","article-title":"cGMP generation of human induced pluripotent stem cells with messenger RNA","volume":"39","author":"Ni","year":"2016","journal-title":"Curr. Protoc. Stem Cell Biol."},{"key":"10.1016\/j.ymthe.2018.12.009_bib56","doi-asserted-by":"crossref","first-page":"10536","DOI":"10.1038\/ncomms10536","article-title":"Whole-genome mutational burden analysis of three pluripotency induction methods","volume":"7","author":"Bhutani","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2018.12.009_bib57","doi-asserted-by":"crossref","first-page":"686","DOI":"10.5966\/sctm.2013-0158","article-title":"Messenger RNA- versus retrovirus-based induced pluripotent stem cell reprogramming strategies: analysis of genomic integrity","volume":"3","author":"Steichen","year":"2014","journal-title":"Stem Cells Transl. Med."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001618305938?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001618305938?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T17:54:40Z","timestamp":1761501280000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001618305938"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":57,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S1525001618305938"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2018.12.009","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"mRNA-Based Genetic Reprogramming","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2018.12.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}